Indivior Pharmaceuticals (INDV) Net Margin (2024 - 2026)
Indivior Pharmaceuticals' (INDV) quarterly Net Margin came in at 28.08% in Q1 2026, up 1003.0% year-on-year from 2.55% in Q1 2025, and down 1.46% quarter-over-quarter from 28.49% in Q4 2025.
Indivior Pharmaceuticals (INDV) Net Margin (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Net Margin history runs 3 years deep, the most recent figure standing at 28.08% for Q1 2026.
- On a quarterly basis, Net Margin rose 1003.0% year-over-year to 28.08% in Q1 2026; TTM through Mar 2026 was 19.44%, a 2004.0% increase from a year earlier, with the FY2025 full-year figure at 16.95%, up 1636.0% from the prior year.
- Net Margin eased to 28.08% in Q1 2026 per INDV's latest filing, from 28.49% in the prior quarter.
- Across five years, Net Margin topped out at 28.49% in Q4 2025 and bottomed at 32.78% in Q2 2024.
- The 3-year median for Net Margin is 13.38% (2025), against an average of 10.8%.
- Biggest YoY gain for Net Margin was 3874 bps in 2025; the steepest drop was 379 bps in 2025.
- Year by year, Net Margin stood at 7.02% in 2024, then surged by 306 bps to 28.49% in 2025, then slipped by 1 bps to 28.08% in 2026.
- Per Business Quant, the three latest INDV Net Margin figures stand at 28.08% (Q1 2026), 28.49% (Q4 2025), and 13.38% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Indivior Pharmaceuticals | 1.00 Bn | 829.65 Mn | 277.00 Mn | 28.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.08% |
| Dec 31, 2025 | 28.49% |
| Sep 30, 2025 | 13.38% |
| Jun 30, 2025 | 5.96% |
| Mar 31, 2025 | 18.05% |
| Dec 31, 2024 | 7.02% |
| Sep 30, 2024 | 7.17% |
| Jun 30, 2024 | -32.78% |
| Mar 31, 2024 | 21.83% |